Robert M. Davis - Apr 30, 2024 Form 4 Insider Report for Merck & Co., Inc. (MRK)

Role
Chairman, CEO & President, Director
Signature
/s/ Kelly E. W. Grez as Attorney-in-Fact for Robert M. Davis
Stock symbol
MRK
Transactions as of
Apr 30, 2024
Transactions value $
$0
Form type
4
Date filed
5/2/2024, 04:14 PM
Previous filing
Feb 15, 2024
Next filing
May 13, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding MRK Common Stock 348K Apr 30, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRK Stock Option (Right to Buy) Award $0 +182K $0.00 182K Apr 30, 2024 Common Stock 182K $129.22 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable in three equal installments on 4/30/2025, 4/30/2026 and 4/30/2027.